Boston Scientific Corp is a leading medical device company headquartered in Marlborough, Massachusetts, United States. The company operates in the Cardiovascular Devices sector, providing innovative medical solutions to healthcare professionals and patients worldwide. Boston Scientific Corp is committed to improving patient outcomes through the development of cutting-edge medical technologies and therapies.

In recent years, Boston Scientific Corp has also been focused on reducing its carbon footprint and contributing to the global effort to decarbonize the economy. The company has recognized the importance of sustainable business practices and has made significant investments in renewable energy and energy efficiency measures.

One of the key initiatives that Boston Scientific Corp has undertaken to reduce its carbon footprint is the implementation of a corporate energy strategy. The company has set ambitious targets to reduce its greenhouse gas emissions and has implemented a range of measures to achieve these targets. These measures include the adoption of energy-efficient technologies, the optimization of energy use in its facilities, and the use of renewable energy sources.

One of the most significant steps that Boston Scientific Corp has taken towards decarbonization is the adoption of corporate power purchase agreements (PPAs) for renewable energy. PPAs are long-term contracts between a company and a renewable energy provider, which guarantee the purchase of a specified amount of renewable energy over a set period. By entering into these agreements, Boston Scientific Corp is able to secure a stable and predictable source of renewable energy, while also supporting the growth of the renewable energy industry.

Boston Scientific Corp has entered into several corporate PPAs for renewable energy, including wind and solar power. In 2019, the company signed a 15-year PPA for 42 MW of wind energy from the Maverick Creek Wind Farm in Texas. This agreement will provide Boston Scientific Corp with approximately 50% of its electricity needs in the United States, and is expected to reduce the company's greenhouse gas emissions by approximately 30,000 metric tons per year.

In addition to its corporate PPAs, Boston Scientific Corp has also invested in on-site renewable energy generation. The company has installed solar panels at several of its facilities, including its headquarters in Marlborough, Massachusetts. These solar installations are expected to generate a significant portion of the company's electricity needs, further reducing its reliance on fossil fuels.

Boston Scientific Corp has also implemented a range of energy efficiency measures to reduce its energy consumption and greenhouse gas emissions. The company has invested in energy-efficient lighting, heating, and cooling systems, as well as building automation systems that optimize energy use. These measures have not only reduced the company's carbon footprint, but have also resulted in significant cost savings.

In conclusion, Boston Scientific Corp is a leading medical device company that is committed to improving patient outcomes through the development of innovative medical technologies and therapies. The company has also recognized the importance of sustainable business practices and has made significant investments in renewable energy and energy efficiency measures. Through its corporate energy strategy, Boston Scientific Corp has set ambitious targets to reduce its greenhouse gas emissions and has implemented a range of measures to achieve these targets. The adoption of corporate PPAs for renewable energy is a key component of the company's decarbonization efforts, and is expected to provide a stable and predictable source of renewable energy while supporting the growth of the renewable energy industry.